Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.
Radiother Oncol
; 148: 270-273, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-401311
ABSTRACT
Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing radiotherapy fractions for cervical cancer patients.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Uterine Cervical Neoplasms
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Radiother Oncol
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS